| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 韩世通 | 中信证券 | 医药生物 | 64.94% | 46.39% | 33.00% | -2.04% | 6 | -63.25% | 2025-09-15 |
| 2 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 64.89% | 65.35% | 36.53% | 12.50% | 7 | -27.10% | 2025-06-23 |
| 3 | 刘浩 | 华创证券 | 医药生物 | 64.84% | 65.65% | 14.01% | 29.41% | 2 | -47.33% | 2025-07-02 |
| 4 | 阳景 | 浦银国际证券 | 医药生物 | 64.83% | 50.73% | 32.67% | 100.00% | 3 | 0.00% | 2025-08-15 |
| 5 | 王道 | 申万宏源 | 医药生物 | 64.82% | 59.41% | 52.82% | 33.33% | 4 | -42.73% | 2025-09-17 |
| 6 | 韩世通 | 中信证券 | 医药生物 | 64.78% | 46.25% | 32.72% | -2.04% | 6 | -63.25% | 2025-09-16 |
| 7 | 阳景 | 浦银国际证券 | 医药生物 | 64.77% | 50.68% | 32.25% | 100.00% | 3 | 0.00% | 2025-08-14 |
| 8 | 阳景 | 浦银国际证券 | 医药生物 | 64.62% | 30.49% | -0.26% | 100.00% | 4 | 0.00% | 2025-10-31 |
| 9 | 唐寅灏 | 中信证券 | 医药生物 | 64.56% | 44.76% | 9.90% | 85.71% | 13 | -8.47% | 2025-10-09 |
| 10 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 64.40% | 59.45% | 30.44% | 12.50% | 7 | -27.10% | 2025-06-20 |
| 11 | 顾资然 | 中信证券 | 医药生物 | 64.38% | 59.95% | 51.96% | 66.67% | 6 | -1.79% | 2025-09-05 |
| 12 | 刘浩 | 华创证券 | 医药生物 | 64.19% | 62.71% | 29.38% | 29.41% | 2 | -47.33% | 2025-06-30 |
| 13 | 刘浩 | 华创证券 | 医药生物 | 64.06% | 50.92% | 35.71% | 29.41% | 2 | -47.33% | 2025-06-05 |
| 14 | 李安飞 | 广发证券 | 医药生物 | 63.97% | 50.60% | 36.68% | -2.86% | 1 | -56.96% | 2025-06-10 |
| 15 | 阳景 | 浦银国际证券 | 医药生物 | 63.88% | 39.44% | 16.50% | 100.00% | 4 | 0.00% | 2025-10-16 |
| 16 | 刘浩 | 华创证券 | 医药生物 | 63.86% | 68.91% | 27.60% | 29.41% | 2 | -47.33% | 2025-07-08 |
| 17 | 刘浩 | 华创证券 | 医药生物 | 63.86% | 67.97% | 36.45% | 29.41% | 2 | -47.33% | 2025-07-07 |
| 18 | 阳景 | 浦银国际证券 | 医药生物 | 63.76% | 41.18% | 15.50% | 100.00% | 4 | 0.00% | 2025-10-13 |
| 19 | 夏禹 | 国联民生 | 医药生物 | 63.67% | 46.63% | 8.42% | 20.00% | 7 | -52.01% | 2025-09-08 |
| 20 | 唐寅灏 | 中信证券 | 医药生物 | 63.65% | 70.87% | 37.65% | 85.71% | 13 | -8.47% | 2025-07-15 |